PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction to “Rimonabant, a Cannabinoid Receptor Type 1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating Liver Kinase B1 and AMP-Activated Protein Kinase Axis Downstream of Gα<sub>i/o</sub> Inhibition”
AID  - 10.1124/mol.82.3.561
DP  - 2012 Sep 01
TA  - Molecular Pharmacology
PG  - 561--562
VI  - 82
IP  - 3
4099  - http://molpharm.aspetjournals.org/content/82/3/561.short
4100  - http://molpharm.aspetjournals.org/content/82/3/561.full
SO  - Mol Pharmacol2012 Sep 01; 82